| 000 | 01780 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250517160141.0 | ||
| 264 | 0 | _c20180416 | |
| 008 | 201804s 0 0 eng d | ||
| 022 | _a1559-0100 | ||
| 024 | 7 |
_a10.1007/s12020-017-1341-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHohendorff, J | |
| 245 | 0 | 0 |
_aA single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 diabetes mellitus. _h[electronic resource] |
| 260 |
_bEndocrine _cAug 2017 |
||
| 300 |
_a272-279 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBenzhydryl Compounds _xtherapeutic use |
| 650 | 0 | 4 |
_aCreatinine _xblood |
| 650 | 0 | 4 |
_aDeoxyglucose _xblood |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucokinase _xgenetics |
| 650 | 0 | 4 |
_aGlucosides _xtherapeutic use |
| 650 | 0 | 4 |
_aGlycosuria _xurine |
| 650 | 0 | 4 |
_aHepatocyte Nuclear Factor 1-alpha _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aSodium-Glucose Transporter 2 |
| 650 | 0 | 4 | _aSodium-Glucose Transporter 2 Inhibitors |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aSzopa, M | |
| 700 | 1 | _aSkupien, J | |
| 700 | 1 | _aKapusta, M | |
| 700 | 1 | _aZapala, B | |
| 700 | 1 | _aPlatek, T | |
| 700 | 1 | _aMrozinska, S | |
| 700 | 1 | _aParpan, T | |
| 700 | 1 | _aGlodzik, W | |
| 700 | 1 | _aLudwig-Galezowska, A | |
| 700 | 1 | _aKiec-Wilk, B | |
| 700 | 1 | _aKlupa, T | |
| 700 | 1 | _aMalecki, M T | |
| 773 | 0 |
_tEndocrine _gvol. 57 _gno. 2 _gp. 272-279 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12020-017-1341-2 _zAvailable from publisher's website |
| 999 |
_c27257509 _d27257509 |
||